Edition:
India

Livzon Pharmaceutical Co Announces Change In Shareholding Structure Of Livzon MABPharm


Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::CO & JOINCARE PHARMACEUTICAL INDUSTRY ENTERED FRAMEWORK AGREEMENT RELATING TO CAPITAL CONTRIBUTION TO LIVZON BIOLOGICS.‍ACQUISITION CONSIDERATION OF 100% OF EQUITY INTERESTS OF LIVZON MAB BY BIOLOGICS TO BE RMB600 MILLION​.